OHSU Cancer Institute physicians validate reclassification of breast cancer stages

June 05, 2006

ATLANTA, Ga. -- Breast cancer is diagnosed as having progressed to any of four stages, Stage IV being the most advanced. The stages are classified by the American Joint Committee on Cancer (AJCC) on the basis of how much the cancer has spread.

In 2002, the AJCC updated its classification system for breast cancer with the publication of its sixth edition of the AJCC Cancer Staging Manual. Now scientists at Oregon Health & Science University Cancer Institute have learned that because of the reclassification, some breast cancer patients may have a higher probability of disease-free survival than previously thought.

The results of the study will be presented on June 5 at the 2006 annual meeting of the American Society of Clinical Oncology in Atlanta, Ga. The presentation is one of eight abstracts either authored or co-authored by members of OHSU's Department of Radiation Medicine (www.ohsu.edu/radonc) to be accepted for presentation at the conference.

"The changes made in the 6th edition of the AJCC guidelines are validated by our study," said Parag Sanghvi, M.P.H., M.D., resident in radiation medicine, OHSU, and one of the study authors. "The reclassification of Stage II and III patients improves our ability to predict prognosis in terms of disease-free survival."

The study analyzed 4,810 patients who were treated at either St. John Medical Center in Longview, Washington, or Southwest Washington Medical Center in Vancouver. Each patient was assigned a disease stage based on both the 5th and 6th editions of the guide.

Patients ranged in age at diagnosis from 20 to 99, with a mean age of 60. The mean length of disease-free follow-up was 224 months (more than 18 years).

The revisions occurred in the two middle classifications, Stages II and III, improving 10-year survival rates in both categories.

As a result of the changes, 13 percent of the patients previously diagnosed with Stage II breast cancer would now be diagnosed with Stage III. Thus, the 10-year survival rate for those with Stage II breast cancer improved, from 66 percent (5th edition) to 72 percent (6th edition). For those with Stage III, the 10-year survival rate also improved, from 30 percent to 36 percent.

The 6th edition classification system has been required for use for cases diagnosed since January 1, 2003.

The study's lead author is Eugene Kim, an undergraduate at Case Western University, in collaboration Sanghvi; Choong R. Kim, M.D., adjunct clinical faculty at OHSU and a physician at St. John Medical Center; Carol Marquez, M.D., associate professor of radiation medicine, OHSU; and Charles R. Thomas, Jr., M.D., professor and chair of radiation medicine, OHSU.
Particulars: ASCO Abstract No.: 6118: Evaluation of Comparative Survival Based on the AJCC 5th and 6th Editions for Breast Cancer Staging: 25-year Experience in Two Southwest Washington State Community Cancer Programs

To access all OHSU news releases, visit www.ohsu.edu/news/

Oregon Health & Science University

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.